Evi-1 as a critical regulator of leukemic cells
- PMID: 20532840
- DOI: 10.1007/s12185-010-0618-5
Evi-1 as a critical regulator of leukemic cells
Abstract
Ecotropic viral integration site-1 (EVI-1) has been recognized as one of the dominant oncogenes associated with murine and human myeloid leukemia. Recent clinical studies demonstrated that high EVI-1 expression was an independent negative prognostic indicator of survival in leukemia patients. In addition, gene-targeting studies in mice reveal that Evi-1 is preferentially expressed in hematopoietic stem cells (HSCs) and plays an essential role in proliferation/maintenance of HSCs. Proteins associated with EVI-1, signaling pathways regulated by EVI-1, and downstream mediators of EVI-1 transcriptional regulation have been described and characterized. In this study, we summarize current knowledge regarding biochemical properties and biological functions of EVI-1, which provides a foundation for the development of novel therapeutic strategies.
Similar articles
-
Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.Cancer Sci. 2009 Jun;100(6):990-5. doi: 10.1111/j.1349-7006.2009.01152.x. Epub 2009 Mar 9. Cancer Sci. 2009. PMID: 19385966 Free PMC article. Review.
-
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.Blood. 2011 Jun 9;117(23):6304-14. doi: 10.1182/blood-2009-07-234310. Epub 2010 Dec 29. Blood. 2011. PMID: 21190993
-
Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.Oncogene. 2009 Dec 10;28(49):4364-74. doi: 10.1038/onc.2009.288. Oncogene. 2009. PMID: 19767769
-
Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.Leukemia. 2015 Feb;29(2):433-40. doi: 10.1038/leu.2014.183. Epub 2014 Jun 6. Leukemia. 2015. PMID: 24903482 Free PMC article.
-
The role of EVI1 in normal and leukemic cells.Blood Cells Mol Dis. 2003 Sep-Oct;31(2):206-12. doi: 10.1016/s1079-9796(03)00159-1. Blood Cells Mol Dis. 2003. PMID: 12972028 Review.
Cited by
-
CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer.Funct Integr Genomics. 2024 Jul 12;24(4):125. doi: 10.1007/s10142-024-01399-8. Funct Integr Genomics. 2024. PMID: 38995475
-
The conserved and divergent roles of Prdm3 and Prdm16 in zebrafish and mouse craniofacial development.Dev Biol. 2020 May 15;461(2):132-144. doi: 10.1016/j.ydbio.2020.02.006. Epub 2020 Feb 8. Dev Biol. 2020. PMID: 32044379 Free PMC article.
-
Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.Oncogene. 2016 May 5;35(18):2311-21. doi: 10.1038/onc.2015.286. Epub 2015 Aug 3. Oncogene. 2016. PMID: 26234679
-
Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.Int J Hematol. 2017 Dec;106(6):811-819. doi: 10.1007/s12185-017-2314-1. Epub 2017 Aug 22. Int J Hematol. 2017. PMID: 28831750
-
Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification.BMC Res Notes. 2016 Mar 2;9:138. doi: 10.1186/s13104-015-1742-3. BMC Res Notes. 2016. PMID: 26935937 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical